Oncotelic Therapeutics, Inc. (OTLC)
0.0371
0.00 (0.00%)
USD |
OTCM |
Apr 07, 16:00
Oncotelic Therapeutics Shareholders Equity (Quarterly) : 9.051M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Johnson & Johnson | 81.54B |
| Supernus Pharmaceuticals, Inc. | 1.062B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Savara, Inc. | 203.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.16M |
| Total Liabilities (Quarterly) | 20.08M |
| Debt to Equity Ratio | 1.607 |
| Current Ratio | 0.0803 |
| Net Debt Paydown Yield | -0.91% |